Effects of lead time, length bias, and false‐negative assurance on screening for breast cancer

This article presents a model of breast cancer screening programs. The model shows the effects of the screening threshold, screen sensitivity, and false‐negative assurance on the cumulative mortality rate in the screened population. It shows that factors of screen design and a penalty associated with false‐negative assurance can result in excess mortality rates in screened populations‐especially in those age classes in which the incidence of rapidly growing tumors is high. Factors related to the magnitude of this effect are described.

[1]  L. Tabár,et al.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.

[2]  S. Shapiro,et al.  Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.

[3]  J. Habbema,et al.  Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. , 1986, Journal of the National Cancer Institute.

[4]  R. Gelman,et al.  Mammography in symptomatic and asymptomatic patients. , 1989, Hematology/oncology clinics of North America.

[5]  R. Tarone,et al.  Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. , 1988, Journal of the National Cancer Institute.

[6]  S. Shapiro,et al.  Lead time in breast cancer detection and implications for periodicity of screening. , 1974, American journal of epidemiology.

[7]  M Moskowitz,et al.  Breast cancer: age-specific growth rates and screening strategies. , 1986, Radiology.

[8]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[9]  M. Moskowitz,et al.  Impact of a priori medical decisions on screening for breast cancer. , 1989, Radiology.

[10]  F R Watson,et al.  The gross rates of growth of human mammary carcinoma , 1972, Cancer.

[11]  D. Lane,et al.  Risk perception, family history, and use of breast cancer screening tests. , 1991, Cancer detection and prevention.

[12]  V. Gebski,et al.  The misuse of mammography in the management of breast cancer revisited , 1989, The Medical journal of Australia.

[13]  M. Fukuda,et al.  Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening , 1990, Japanese journal of cancer research : Gann.

[14]  A. Crucitti,et al.  Diagnostic Delay in Breast Cancer: Correlation with Disease Stage and Prognosis , 1990, Tumori.